


Ask a doctor about a prescription for Septogard Plus
Septogard Plus, (1.5 mg + 5 mg)/ml, oral spray, solution
Benzydamine hydrochloride + Cetylpyridinium chloride
This medicine should always be used exactly as described in this package leaflet for the patient or as directed by a doctor or pharmacist.
Septogard Plus is an anti-inflammatory, analgesic, and antiseptic medicine for local use in the mouth. The oral spray disinfects the mouth and throat and reduces symptoms of throat inflammation, such as pain, redness, swelling, feeling of heat, and disturbance of function.
Septogard Plus is used in adults and adolescents over 12 years of age as an anti-inflammatory, analgesic, and antiseptic for the treatment of:
If there is no improvement or the patient feels worse after 3 days, a doctor should be consulted.
Before starting to use Septogard Plus, the doctor or pharmacist should be consulted.
Septogard Plus should not be used for more than 7 days. If symptoms worsen or do not improve after 3 days, or if other symptoms such as fever occur, a doctor should be consulted.
The use of local medicines, especially for a longer period, may lead to irritation. In such cases, treatment should be discontinued.
Septogard Plus should not be used in combination with anionic compounds, such as those found in toothpastes, and it is not recommended to use the medicine directly before or after brushing teeth.
Direct contact between Septogard Plus and the eyes should be avoided.
This medicine should not be inhaled.
Septogard Plus should not be used in children under 6 years of age, as the oral spray is not intended for this age group.
Septogard Plus should not be used in children between 6 and 12 years of age unless a doctor recommends otherwise.
The doctor or pharmacist should be informed about all medicines the patient is currently taking or has recently taken, as well as any medicines the patient plans to take.
Septogard Plus should not be used at the same time as other antiseptic products.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a baby, they should consult a doctor or pharmacist before using this medicine.
Septogard Plus is not recommended during pregnancy.
Before using Septogard Plus during breastfeeding, the doctor should be consulted.
The doctor will decide whether to discontinue breastfeeding or stop treatment with Septogard Plus.
Septogard Plus has no or negligible influence on the ability to drive and use machines.
Macrogolglycerol hydroxystearate may cause gastrointestinal disorders and diarrhea.
This medicine contains less than 1 mmol (23 mg) of sodium per dose, which means it is essentially 'sodium-free'.
This medicine should always be used exactly as described in this package leaflet for the patient or as directed by a doctor or pharmacist.
To obtain a single dose, the pump head of the spray should be pressed once or twice. The dose can be repeated every 2 hours, 3 to 5 times a day.
Adolescents over 12 years of age
To obtain a single dose, the pump head of the spray should be pressed once or twice. The dose can be repeated every 2 hours, 3 to 5 times a day.
Septogard Plus should not be used in children under 12 years of age.
The recommended dose should not be exceeded.
For optimal effect, it is not recommended to use the medicine directly before or after brushing teeth.
Before the first use of Septogard Plus, the pump head of the spray should be pressed at least 3-4 times until a uniform spray is obtained. If the medicine has not been used for a longer period (at least one week), the pump head of the spray should be pressed 1-2 times to obtain a uniform spray.
The mouth should be opened wide, the applicator directed towards the throat, and the pump head of the spray pressed 1-2 times.
During spraying, the breath should be held.
This medicine should not be used for more than 7 days. If symptoms worsen or do not improve after 3 days, or if other symptoms such as fever occur, a doctor should be consulted.
A doctor should be consulted if the condition is recurrent or if new changes in its characteristics are observed.
In case of overdose or accidental ingestion of a large amount of the medicine, a doctor or pharmacist should be consulted immediately.
A double dose should not be used to make up for a missed dose.
If there are any further doubts about the use of the medicine, a doctor or pharmacist should be consulted.
Like all medicines, Septogard Plus can cause side effects, although not everybody gets them.
Rare (may affect up to 1 in 1000 people):
Very rare (may affect up to 1 in 10,000 people):
Frequency not known (cannot be estimated from the available data):
These symptoms are usually temporary. However, if they occur, a doctor or pharmacist should be consulted.
By following the instructions in the package leaflet, the risk of side effects can be minimized.
If any side effects occur, including those not listed in the package leaflet, the doctor or pharmacist should be informed.
Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309,
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, more information can be gathered on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
This medicine should not be used after the expiry date stated on the packaging after 'EXP'. The expiry date refers to the last day of the month stated.
There are no special storage conditions for this medicine.
This medicine should not be used for more than 6 months after first opening. There are no special storage conditions after first opening.
Medicines should not be disposed of via wastewater or household waste. A pharmacist should be asked how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substances are benzydamine hydrochloride and cetylpyridinium chloride.
Each ml of the oral spray, solution contains 1.5 mg of benzydamine hydrochloride and 5 mg of cetylpyridinium chloride (as cetylpyridinium chloride monohydrate).
One spray contains 0.1 ml of the oral spray, solution, containing 0.15 mg of benzydamine hydrochloride and 0.5 mg of cetylpyridinium chloride (as cetylpyridinium chloride monohydrate).
The other ingredients are glycerol (E 422), sodium saccharin, macrogolglycerol hydroxystearate, peppermint flavor (contains: natural peppermint essential oil, natural peppermint extract, maltodextrin, menthofuran, pulegone, arabic gum (E 414)), and purified water.
Septogard Plus is a clear, colorless solution.
A polyethylene (HDPE) bottle with a pump dispenser (PE/POM/EVA/stainless steel/aluminum/silicone emulsion) and an applicator (PP/HDPE): 30 ml of the oral spray, solution in a cardboard box.
Farmak International Sp. z o.o.
ul. Koszykowa 65
00-667 Warsaw
tel. +48 22 822 93 06
Symphar Sp. z o.o.
ul. Chełmżyńska 249
04-458 Warsaw
Lithuania: Benzydamine hydrochloride/Cetylpyridinium chloride Farmak 1.5 mg/5 mg/ml burnos gleivinės purškalas (tirpalas)
Poland: Septogard Plus
5
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Septogard Plus – subject to medical assessment and local rules.